
Europe Risks Losing Its Pharmaceutical Crown Jewel
Europe's pharmaceutical sector faces decline due to geopolitical instability and lack of domestic support, falling behind the US and China in innovation, R&D, and clinical trials. Urgent action is needed to rebuild its ecosystem.




















